2-(4-(5-(3-Acetamidophenyl)-2-(2-aminopyridin-3-yl)-3Himidazo[4,5-b]pyridin-3-yl)phenyl)-N-(3-fluorophenyl)-acetamide

ID: ALA2177828

PubChem CID: 58345232

Max Phase: Preclinical

Molecular Formula: C33H26FN7O2

Molecular Weight: 571.62

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(=O)Nc1cccc(-c2ccc3nc(-c4cccnc4N)n(-c4ccc(CC(=O)Nc5cccc(F)c5)cc4)c3n2)c1

Standard InChI:  InChI=1S/C33H26FN7O2/c1-20(42)37-24-7-2-5-22(18-24)28-14-15-29-33(39-28)41(32(40-29)27-9-4-16-36-31(27)35)26-12-10-21(11-13-26)17-30(43)38-25-8-3-6-23(34)19-25/h2-16,18-19H,17H2,1H3,(H2,35,36)(H,37,42)(H,38,43)

Standard InChI Key:  XZDBUFJDOOKECF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 43 48  0  0  0  0  0  0  0  0999 V2000
    0.0275   -9.5958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0263  -10.4153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7344  -10.8243    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7326   -9.1869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4412   -9.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4460  -10.4108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2260  -10.6592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7034   -9.9941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2183   -9.3347    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6377  -11.3596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2322  -12.0703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6449  -12.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4629  -12.7697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8665  -12.0543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4515  -11.3528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5186   -9.9888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9307  -10.6957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7472  -10.6912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1524   -9.9806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7352   -9.2730    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9202   -9.2809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5055   -8.5768    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8772  -13.4741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6944  -13.4675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1087  -14.1719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0973  -12.7565    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7058  -14.8829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8876  -14.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4849  -15.5961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8992  -16.3014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7206  -16.2922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1197  -15.5815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6822  -10.8236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3943  -10.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0982  -10.8201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0972  -11.6382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3897  -12.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6829  -11.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8026  -10.4106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8036   -9.5934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5162   -9.1839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1003   -9.1857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1374  -16.9951    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 10  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  8 16  1  0
 21 22  1  0
 13 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 33  1  0
  2 33  1  0
 35 39  1  0
 39 40  1  0
 40 41  1  0
 40 42  2  0
 31 43  1  0
M  END

Associated Targets(Human)

AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AN3-CA (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 571.62Molecular Weight (Monoisotopic): 571.2132AlogP: 6.01#Rotatable Bonds: 7
Polar Surface Area: 127.82Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.36CX Basic pKa: 5.89CX LogP: 5.35CX LogD: 5.34
Aromatic Rings: 6Heavy Atoms: 43QED Weighted: 0.22Np Likeness Score: -1.56

References

1. Ashwell MA, Lapierre JM, Brassard C, Bresciano K, Bull C, Cornell-Kennon S, Eathiraj S, France DS, Hall T, Hill J, Kelleher E, Khanapurkar S, Kizer D, Koerner S, Link J, Liu Y, Makhija S, Moussa M, Namdev N, Nguyen K, Nicewonger R, Palma R, Szwaya J, Tandon M, Uppalapati U, Vensel D, Volak LP, Volckova E, Westlund N, Wu H, Yang RY, Chan TC..  (2012)  Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitors.,  55  (11): [PMID:22533986] [10.1021/jm300276x]

Source